Extracorporeal Hyperthermia Perfusion (EHP) | Centre of Advanced Medicine, Frankfurt, Germany

Introducing extracorporeal hyperthermia perfusion (EHP), an innovative therapy that combines the best of hemoperfusion, hyperthermia, oxygenation, and apheresis to treat a wide range of health conditions. From cancers and Lyme disease to autoimmune diseases, chronic illnesses, and heavy metal pollution-related disorders, the therapy is highly effective and minimizes the risk of side effects. With EHP, you can take control of your health and experience the benefits of a comprehensive, self-contained treatment. The EHP consists of the following:Hemo-hyperthermia. Hemo-hyperthermia is a unique cancer treatment that involves warming the blood to a specific temperature range of 40°C to 42. 0°C and then reinfusing it into the body. Unlike other hyperthermia methods that warm the body from the outside, hemo-hyperthermia directly warms the blood, allowing for higher concentrations of cytostatic drugs to be delivered directly to the affected target organs. This method is particularly effective in cancer treatment because it enables cytostatics to be delivered at much higher concentrations than in conventional chemotherapy, resulting in more targeted, effective treatment with fewer side effects. Additionally, the excess cytostatics can be removed from the organism at the end of treatment using a specialized technique, further reducing the risk of side effects. Hemoperfusion. It is a medical procedure that removes harmful and inflammatory molecules from the human blood. This helps regulate metabolism, boost the immune system, and improve the effectiveness of various medication strategies. At our facility, we use various techniques to remove heavy metal contamination from blood in a single treatment. First, chelating agents are infused to mobilize heavy metals from tissues into the bloodstream, and heat is then applied to maximize this process. The heavy metals are then filtered from the blood. Our hemoperfusion procedure is suitable for treating sepsis, severe inflammation, cytokines, and various toxins. It is also effective for treating Lyme disease, autoimmune diseases, cancer, multiple organ failure, liver and kidney diseases, systemic inflammatory response syndrome, lung diseases such as acute respiratory distress syndrome, and other blood-related conditions. This treatment significantly increases effectiveness and can provide numerous benefits to patients. Hyperoxygenated hemoperfusion. It can be extended by using an oxygenator originally developed for cardiac surgery, now used in numerous therapeutic disciplines. By administering medical oxygen, oxygen saturation in the tissue can exceed 700%. This high level of oxygen saturation triggers the body's own repair and regeneration processes, stimulates neovascularization, and enhances the elimination of toxins from the body. The EHP has revolutionized the treatment of various medical conditions by enabling the maintenance of a constant core body temperature of up to 42. 0 °C for more than 3 hours. This temperature control technology is highly effective in treating a range of conditions with minimal impact on the patient. What are the indications?Autoimmune diseases (such as multiple sclerosis, Crohn’s disease, ulcerative colitis, Hashimoto’s thyroiditis, and many others);Lyme disease;Cancer;Liver disease;Lung disease (ARDS);Kidney disease;Sepsis;Suspected multiple organ failure;Heavy metal pollution;Rheumatic disorders (arthritis, arthrosis, gout, etc. ).